The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19

Q Hu, Y Xiong, GH Zhu, YN Zhang, YW Zhang… - MedComm, 2022 - Wiley Online Library
The main proteases (Mpro), also termed 3‐chymotrypsin‐like proteases (3CLpro), are a
class of highly conserved cysteine hydrolases in β‐coronaviruses. Increasing evidence has …

Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update

L Hillebrand, XJ Liang, RAM Serafim… - Journal of Medicinal …, 2024 - ACS Publications
Covalent inhibitors and other types of covalent modalities have seen a revival in the past two
decades, with a variety of new targeted covalent drugs having been approved in recent …

Structure-guided design of potent spirocyclic inhibitors of severe acute respiratory syndrome coronavirus-2 3C-like protease

CS Dampalla, AD Rathnayake… - Journal of medicinal …, 2022 - ACS Publications
The worldwide impact of the ongoing COVID-19 pandemic on public health has made
imperative the discovery and development of direct-acting antivirals aimed at targeting viral …

Advances in research on 3C-like protease (3CL pro) inhibitors against SARS-CoV-2 since 2020

R Chen, Y Gao, H Liu, H Li, W Chen, J Ma - RSC Medicinal Chemistry, 2023 - pubs.rsc.org
COVID-19 caused by SARS-CoV-2 in late 2019 is still threatening global human health.
Although some vaccines and drugs are available in the market, controlling the spread of the …

Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors

A Wu, K Shi, J Wang, R Zhang, Y Wang - European Journal of Medicinal …, 2023 - Elsevier
The COVID-19 pandemic, caused by SARS-CoV-2, has had a huge impact on global health.
To respond to rapidly mutating viruses and to prepare for the next pandemic, there is an …

The expanding repertoire of covalent warheads for drug discovery

NV Mehta, MS Degani - Drug Discovery Today, 2023 - Elsevier
The reactive functionalities of drugs that engage in covalent interactions with the
enzyme/receptor residue in either a reversible or an irreversible manner are …

A Novel Y-shaped, S–O–N–O–S-bridged cross-link between three residues C22, C44, and K61 is frequently observed in the SARS-CoV-2 main Protease

KS Yang, LR Blankenship, STA Kuo… - ACS chemical …, 2023 - ACS Publications
As the COVID-19 pathogen, SARS-CoV-2 relies on its main protease (MPro) for
pathogenesis and replication. During crystallographic analyses of MPro crystals that were …

Structure-based discovery of novel cruzain inhibitors with distinct trypanocidal activity profiles

VC Santos, PG Leite, LH Santos, PG Pascutti… - European Journal of …, 2023 - Elsevier
Over 110 years after the first formal description of Chagas disease, the trypanocidal drugs
thus far available have limited efficacy and several side effects. This encourages the search …

Broad-spectrum cyclopropane-based inhibitors of coronavirus 3C-like proteases: biochemical, structural, and virological studies

CS Dampalla, HN Nguyen… - ACS Pharmacology & …, 2022 - ACS Publications
The advent of SARS-CoV-2, the causative agent of COVID-19, and its worldwide impact on
global health, have provided the impetus for the development of effective countermeasures …

Bisphenol a modification and how its structure influences human serum albumin binding force

X Hu, JZ Wang, QH Liu, X Ding, MM Yin… - Journal of Molecular …, 2024 - Elsevier
Bisphenol A (BPA) is an environmental hormone with substantial physiological toxicity to the
human body. Three electron-withdrawing derivatives of BPA are synthesized in this study to …